Dr. Jacqueline Garcia

Dr. Jacqueline Garcia presents results of a trial using venetoclax in stem cell transplants.

Dana-Farber Cancer Institute

Drs. Anthony Letai and Jacqueline Garcia on Dana-Farber’s Momentum of Discovery

Dana-Farber Cancer Institute

Jacqueline Garcia: Evaluating Venetoclax Plus Azacitidine in Patients with High-Risk MDS

American Society of Hematology

Topics of interest in MDS: the role of maintenance therapy, immune checkpoints & VEN-AZA in HR-MDS

VJHemOnc – Video Journal of Hematology & HemOnc

New and Emerging AML Therapies Being Studied in Clinical Trials

Patient Empowerment Network

Acute Myeloid Leukemia Care | Who Are the Essential Team Members?

Patient Empowerment Network

The impact of mutation screening on transplant decisions in MDS

VJHemOnc – Video Journal of Hematology & HemOnc

OVERCOMING NURSING BURNOUT

USA GLOBAL TV ® & RADIO

Jacqueline Garcia, MD, on treating acute leukemias in adults.

Dana-Farber Cancer Institute

Immune therapy approaches in MDS

VJHemOnc – Video Journal of Hematology & HemOnc

Venetoclax in combination with azacitidine for patients with treatment-naïve HR-MDS

VJHemOnc – Video Journal of Hematology & HemOnc

AML Specialists and Second Opinions | Expert Advice to Patients

Patient Empowerment Network

Dr. Garcia Discusses Immune Therapy Approaches in MDS

Blood Cancers Today

Thriving With AML | Tips and Support for Navigating Treatment

Patient Empowerment Network

Understanding AML Treatment Categories

Patient Empowerment Network

Combination AML Therapy for Newly Diagnosed Patients | What Are the Long-Term Effects?

Patient Empowerment Network

Treatments for MDS and Secondary AML - Part 2, High-Risk

Jacqueline Garcia: Evaluating Navitoclax for Myelofibrosis

American Society of Hematology

Venetoclax plus azacitidine for higher-risk MDS

VJHemOnc – Video Journal of Hematology & HemOnc